This order includes a Tirzepatide 20mg weight loss program – initial dosage lasts 6 weeks to get you started, a Telemedicine evaluation & training, clinical support and a reorder discount coupon for when you are ready to move on to the larger Tirzepatide 50mg vial. This plan includes a compounded medication made by our compounding pharmacy, all training and clinical phone support is included with each purchase.
Order processing times are between 1-2 days, pharmacy compounding times take 5-8 business days on average.
The therapy and medications needed may only be shipped to certain states, if you input your address upon checkout and it says “No Shipping Available” it means the pharmacy license for that state does not exist. This is a cold shipped item. All Telemedicine orders require a phone evaluation with one of our providers to ensure safety.
Must have a BMI of 27+ (Not sure what your BMI is? Calculate it HERE)
Tirzepatide compounded 20mg therapy
Tirzepatide compounded 20mg kit contains:
(1) 2ml Vial of Tirzepatide 10mg/ml
31guage 5/16″ Insulin needles for injection
70% Alcohol swabs for sterilizations
Phone/Video/In-Person Physician Evaluation
Duration: The duration of each vial is determined by your individual dose, the higher dose, the faster you will require a refill.
At Medclub we have created our Tirzepatide 20mg weight loss program for patients who want an effective weight loss option, as well as patients resistant to Semaglutide. Our program helps obese patients receive the help they need while brand name manufacturers struggle with medication shortages. Our Tirzepatide program utilizes a compounded substitution made by 3rd party compounding pharmacists that are licensed under section 503A, dosage, potency, & volume may vary. Tirzepatide has less reported side effects, and typically works slightly faster than semaglutide due to the differences in chemical structure. Both medications are GLP-1 agonists but Tirzepatide is also a GIP agonist. Patients may observe a lower A1C with consistent appetite suppression, and consistent weight loss with prolonged administration when paired with proper diet & exercise.
Tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the Food and Drug Administration [FDA] for type 2 diabetes) engineered from the native GIP sequence, with agonist activity at both the GIP and GLP-1 receptors.
Interested in reading about clinical trials, click here: NCT04184622.
- diabetic retinopathy, a type of damage to the eye from diabetes.
- stomach muscle paralysis and decreased function.
- disease of the gallbladder.
- decreased kidney function.
- medullary thyroid cancer.
- multiple endocrine neoplasia type 2.
- Diabetes Type I
This program may include compounded medications that are clinical substitutions of brand name medications compounded by licensed compounding pharmacies under section 503A. To learn more about the benefits, risks, & differences of compounded medication substitutes you may visit the FDA Drug Shortage List & FDA Compounding Substitutions Information Page. MedClub only utilizes pharmacies in the United States that adhere to the standards of practices under 503A, 503B, & 503C active licensing and acts in good faith that these standards will be upheld by each licensed compounding pharmacy. These compounds may have deviations from the brand name substitute. If you have questions about compounded medications, the approval process, testing requirements or licensing patients must contact their dispensing 3rd party pharmacy directly. There are NO REFUNDS on these medications except for direct replacements by the Pharmacy of Origin in the event the package is lost/damaged by the courier. This process requires a case to be opened with the pharmacy directly, MedClub makes no claims or guarantees about results.
Credit – New England Journal of Medicine, Yale Medicine